US Patent Issued to ASCLETIS PHARMA (CHINA) on Sept. 8 for "GLP-1R agonist and therapeutic method thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,200, issued on Sept. 8, was assigned to ASCLETIS PHARMA (CHINA) Co. Ltd. (Hong Kong).

"GLP-1R agonist and therapeutic method thereof" was invented by Bin Liang (Hong Kong), Jinzi Jason Wu (Hong Kong) and Bailing Yang (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure describes GLP-1R modulating compounds that are useful for treating GLP-1R-mediated diseases or conditions,"

The patent was filed on July 16, 2025, under Application No. 19/271,557.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-...